US 11066417
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
granted A61KA61K31/404A61K31/439
Quick answer
US patent 11066417 (Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 47
- CPC classes
- A61K, A61K31/404, A61K31/439, A61K31/47, A61P